An Australian-led trial found a personalised melanoma vaccine cuts the risk of cancer returning or death by 42%.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results